Trend shifting from treatment to prevention, screening: Shravan Subramanyam

We recently launched digital pathology where everything is now done digitally, says Subramanyam

Roche Diagnostics India, the diagnostics division of pharma major Hoffmann-La Roche, has been in India for over 50 years through various entities. Now, with full-fledged operations in India, the firm is focusing on infectious diseases, oncology, cardiac and metabolic disorders, non-communicable diseases, and women’s health. In an interaction with Gireesh Babu, Managing Director of Roche Diagnostics India, Shravan Subramanyam, talks about emerging trends and the future of the diagnostics market. Edited excerpts:

What are the trends in the diagnostics industry you observe in India and are trying to adopt?

The trend is moving from treatment to prevention and screening. There is a